Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 6/20 | 0.62 |
| ▸ | KDM1A | O60341 | 3/20 | 0.62 |
| ▸ | NPY2R | P49146 | 7/20 | 0.60 |
| ▸ | NPY4R | P50391 | 7/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.60 |
| ▸ | NPY1R | P25929 | 5/20 | 0.60 |
| ▸ | MAOB | P27338 | 1/20 | 0.59 |
| ▸ | KDM5A | P29375 | 1/20 | 0.59 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.59 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.58 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.57 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.57 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29856103 | 0.95 | TFPI (0.60) | TFPIKDM1ANPY2RNPY4RNPY5R | |
| SCHEMBL29903316 | 0.91 | NPY2R (0.64) | TFPIKDM1ANPY2RNPY4RNPY5R | |
| SCHEMBL31182515 | 0.90 | TFPI (0.68) | TFPIKDM1ANPY2RNPY4RNPY5R | |
| SCHEMBL30924728 | 0.90 | EPHA2 (0.65) | TFPIKDM1ANPY2RNPY4RNPY5R | |
| SCHEMBL31182494 | 0.89 | NPY2R (0.69) | TFPIKDM1ANPY2RNPY4RNPY5R | |
| SCHEMBL30578762 | 0.89 | NTSR2 (0.60) | KDM1ANPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29356641 | 0.88 | KDM1A (0.65) | TFPIKDM1ANPY2RNPY4RNPY5R | |
| SCHEMBL30176462 | 0.88 | NPY2R (0.68) | TFPIKDM1ANPY2RNPY4RNPY5R | |
| SCHEMBL30567732 | 0.88 | TFPI (0.64) | TFPIKDM1ANPY2RNPY4RNPY5R | |
| SCHEMBL30335912 | 0.88 | NPY2R (0.60) | TFPIKDM1ANPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4267193-A1 | IMPROVED CD30 TARGETING ANTIBODY DRUG CONJUGATES AND USES THEREOF | Ludwig-Maximilians-Universität München (DE) | 2023-11-01 | — | — | EP | disclosed |
| WO-2022136555-A1 | IMPROVED CD30 TARGETING ANTIBODY DRUG CONJUGATES AND USES THEREOF | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE) | 2022-06-30 | — | — | WO | disclosed |